The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-The Kidstherapy

Citation:
Du R, Yang H, Zhou H, Ma L, Getu MA, Chen C, Wang T. The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-The Kids therapy. BMC Cancer. 2022;22(1).

Keywords:
EGFR-The Kids; Medication literacy; Skin adverse drug reactions; Targeted therapy; interleukin 6; protein kinase inhibitor; adverse drug reaction; cross-sectional study; lung tumor; non small cell lung cancer; Protein Kinase Inhibitors

Abstract:
High medication literacy is the basis of rational medication application and is essential for the management of severe adverse drug reactions. The objective of the present study was to assess the level of medication literacy and determine the association between medication literacy and skin adverse drug reactions in non-small-cell lung cancer (NSCLC) patients undergoing targeted epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-The Kids) therapy.